Treace Medical Concepts announced commercial launch of the Adductoplasty™ System. Adductoplasty combines Treace’s implants and instrumentation for the first comprehensive system designed for reproducible realignment, stabilization, and fusion of the midfoot.
“The Adductoplasty System further advances our market leadership position in the surgical management of hallux valgus by providing surgeons with a precision, instrumented approach to treat both the bunion and coexisting midfoot deformities. With a potential for up to 30% of bunion patients in the U.S. to also be affected by concomitant midfoot deformities, we see a significant opportunity to provide a more comprehensive treatment for these patients,” said John T. Treace, CEO of Treace Medical.
Source: Treace Medical Concepts